The US Food and Drug Administration has approved a vaccine against respiratory syncytial virus (RSV), an illness that kills thousands of Americans each year. The vaccine still needs approval from the US Centers for Disease Control and Prevention before it can be rolled out to the public. Officials say the vaccine, named Arexvy by the manufacturer GSK, is a major breakthrough that will save many lives.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Two-day pharma and healthcare expo kickstarts

Lahore: Pak Pharma and Healthcare expo in collaboration with the Pakistan Pharmaceutical…

Punjab changes admission policy for medical, dental colleges

The Punjab education authorities have changed the admission policy for the government…

Trio wins Nobel Chemistry Prize for quantum dots

French-born Moungi Bawendi, Louis Brus of the United States and Russian-born Alexei…

US, Hungarian scientists win Nobel for research on Covid vaccines

Scientists Katalin Kariko of Hungary and Drew Weissman of the United States…